THE THOC1 RIBONUCLEOPROTEIN AS A NOVEL BIOMARKER FOR PROSTATE CANCER TREATMENT ASSIGNMENT

$811,040FY2014Department of DefenseDOD

Health Research, Inc., Rockville MD

Investigators